One Codex
DE - WilmingtonBiotechnology
Focus: One Codex operates a microbiome sequencing platform focused on gastroenterology applications, positioning itself in the precision diagnostics and sequencing infrastructure space.
Profile data last refreshed 3h ago · AI intelligence enriched 1mo ago
Open Jobs
6+5 this month
Growing — net +5 jobs in 30d
7 jobs added vs 2 removed. Steady team buildout.
Should You Work at One Codex?
AI assessmentBest suited for mission-driven scientists willing to accept pre-commercial risk for early-stage platform influence in a high-potential field.
Why Work Here
- Early-stage microbiome sequencing platform with focused therapeutic area (gastroenterology) offers technical depth in genomics and diagnostics
- Opportunity to shape product-market fit and platform development from foundational stage
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Growing
Jobs increasing
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for One Codex
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.